Selected research
Market Structure
Global Captopril Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Captopril Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Captopril Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Captopril Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Captopril Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Captopril Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Captopril Tablets include Accord Healthcare, Apotex, A-S Medication Solutions, Baker Cummins, Camber Pharmaceutical, Par Pharmaceutical, Preferred Pharmaceuticals, Pidi Pharmaceutical and Changzhou Pharmaceutical Factory, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Captopril Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Captopril Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Captopril Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Captopril Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Captopril Tablets Segment by Company
Accord Healthcare
Apotex
A-S Medication Solutions
Baker Cummins
Camber Pharmaceutical
Par Pharmaceutical
Preferred Pharmaceuticals
Pidi Pharmaceutical
Changzhou Pharmaceutical Factory
Sandoz
TEVA
Zhongjie Pharmaceutical
Captopril Tablets Segment by Type
25mg Tablet
50mg Tablet
Others
Captopril Tablets Segment by Application
Clinics
Hospitals
Others
Captopril Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Captopril Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Captopril Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Captopril Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Captopril Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Captopril Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Captopril Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Captopril Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 25mg Tablet
- 50mg Tablet
- Others
Applications
- Clinics
- Hospitals
- Others
Companies covered
- Accord Healthcare
- Apotex
- A-S Medication Solutions
- Baker Cummins
- Camber Pharmaceutical
- Par Pharmaceutical
- Preferred Pharmaceuticals
- Pidi Pharmaceutical
- Changzhou Pharmaceutical Factory
- Sandoz
- TEVA
- Zhongjie Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Captopril Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Captopril Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Captopril Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Captopril Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Captopril Tablets Market Dynamics
- 2.1 Captopril Tablets Industry Trends
- 2.2 Captopril Tablets Industry Drivers
- 2.3 Captopril Tablets Industry Opportunities and Challenges
- 2.4 Captopril Tablets Industry Restraints
3 Captopril Tablets Market by Manufacturers
- 3.1 Global Captopril Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Captopril Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Captopril Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Captopril Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Captopril Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Captopril Tablets Manufacturers, Product Type & Application
- 3.7 Global Captopril Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Captopril Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Captopril Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Captopril Tablets Tier 1, Tier 2, and Tier 3
4 Captopril Tablets Market by Type
- 4.1 Captopril Tablets Type Introduction
- 4.1.1 25mg Tablet
- 4.1.2 50mg Tablet
- 4.1.3 Others
- 4.2 Global Captopril Tablets Sales by Type
- 4.2.1 Global Captopril Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Captopril Tablets Sales by Type (2021-2032)
- 4.2.3 Global Captopril Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Captopril Tablets Revenue by Type
- 4.3.1 Global Captopril Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Captopril Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Captopril Tablets Revenue Market Share by Type (2021-2032)
5 Captopril Tablets Market by Application
- 5.1 Captopril Tablets Application Introduction
- 5.1.1 Clinics
- 5.1.2 Hospitals
- 5.1.3 Others
- 5.2 Global Captopril Tablets Sales by Application
- 5.2.1 Global Captopril Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Captopril Tablets Sales by Application (2021-2032)
- 5.2.3 Global Captopril Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Captopril Tablets Revenue by Application
- 5.3.1 Global Captopril Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Captopril Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Captopril Tablets Revenue Market Share by Application (2021-2032)
6 Global Captopril Tablets Sales by Region
- 6.1 Global Captopril Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Captopril Tablets Sales by Region (2021-2032)
- 6.2.1 Global Captopril Tablets Sales by Region (2021-2026)
- 6.2.2 Global Captopril Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Captopril Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Captopril Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Captopril Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Captopril Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Captopril Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Captopril Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Captopril Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Captopril Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Captopril Tablets Revenue by Region
- 7.1 Global Captopril Tablets Revenue by Region
- 7.1.1 Global Captopril Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Captopril Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Captopril Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Captopril Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Captopril Tablets Revenue (2021-2032)
- 7.2.2 North America Captopril Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Captopril Tablets Revenue (2021-2032)
- 7.3.2 Europe Captopril Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Captopril Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Captopril Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Captopril Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Captopril Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Accord Healthcare
- 8.1.1 Accord Healthcare Company Information
- 8.1.2 Accord Healthcare Business Overview
- 8.1.3 Accord Healthcare Captopril Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Accord Healthcare Captopril Tablets Product Portfolio
- 8.1.5 Accord Healthcare Recent Developments
- 8.2 Apotex
- 8.2.1 Apotex Company Information
- 8.2.2 Apotex Business Overview
- 8.2.3 Apotex Captopril Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Apotex Captopril Tablets Product Portfolio
- 8.2.5 Apotex Recent Developments
- 8.3 A-S Medication Solutions
- 8.3.1 A-S Medication Solutions Company Information
- 8.3.2 A-S Medication Solutions Business Overview
- 8.3.3 A-S Medication Solutions Captopril Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 A-S Medication Solutions Captopril Tablets Product Portfolio
- 8.3.5 A-S Medication Solutions Recent Developments
- 8.4 Baker Cummins
- 8.4.1 Baker Cummins Company Information
- 8.4.2 Baker Cummins Business Overview
- 8.4.3 Baker Cummins Captopril Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Baker Cummins Captopril Tablets Product Portfolio
- 8.4.5 Baker Cummins Recent Developments
- 8.5 Camber Pharmaceutical
- 8.5.1 Camber Pharmaceutical Company Information
- 8.5.2 Camber Pharmaceutical Business Overview
- 8.5.3 Camber Pharmaceutical Captopril Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Camber Pharmaceutical Captopril Tablets Product Portfolio
- 8.5.5 Camber Pharmaceutical Recent Developments
- 8.6 Par Pharmaceutical
- 8.6.1 Par Pharmaceutical Company Information
- 8.6.2 Par Pharmaceutical Business Overview
- 8.6.3 Par Pharmaceutical Captopril Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Par Pharmaceutical Captopril Tablets Product Portfolio
- 8.6.5 Par Pharmaceutical Recent Developments
- 8.7 Preferred Pharmaceuticals
- 8.7.1 Preferred Pharmaceuticals Company Information
- 8.7.2 Preferred Pharmaceuticals Business Overview
- 8.7.3 Preferred Pharmaceuticals Captopril Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Preferred Pharmaceuticals Captopril Tablets Product Portfolio
- 8.7.5 Preferred Pharmaceuticals Recent Developments
- 8.8 Pidi Pharmaceutical
- 8.8.1 Pidi Pharmaceutical Company Information
- 8.8.2 Pidi Pharmaceutical Business Overview
- 8.8.3 Pidi Pharmaceutical Captopril Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Pidi Pharmaceutical Captopril Tablets Product Portfolio
- 8.8.5 Pidi Pharmaceutical Recent Developments
- 8.9 Changzhou Pharmaceutical Factory
- 8.9.1 Changzhou Pharmaceutical Factory Company Information
- 8.9.2 Changzhou Pharmaceutical Factory Business Overview
- 8.9.3 Changzhou Pharmaceutical Factory Captopril Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Changzhou Pharmaceutical Factory Captopril Tablets Product Portfolio
- 8.9.5 Changzhou Pharmaceutical Factory Recent Developments
- 8.10 Sandoz
- 8.10.1 Sandoz Company Information
- 8.10.2 Sandoz Business Overview
- 8.10.3 Sandoz Captopril Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Sandoz Captopril Tablets Product Portfolio
- 8.10.5 Sandoz Recent Developments
- 8.11 TEVA
- 8.11.1 TEVA Company Information
- 8.11.2 TEVA Business Overview
- 8.11.3 TEVA Captopril Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 TEVA Captopril Tablets Product Portfolio
- 8.11.5 TEVA Recent Developments
- 8.12 Zhongjie Pharmaceutical
- 8.12.1 Zhongjie Pharmaceutical Company Information
- 8.12.2 Zhongjie Pharmaceutical Business Overview
- 8.12.3 Zhongjie Pharmaceutical Captopril Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Zhongjie Pharmaceutical Captopril Tablets Product Portfolio
- 8.12.5 Zhongjie Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Captopril Tablets Value Chain Analysis
- 9.1.1 Captopril Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Captopril Tablets Production Mode & Process
- 9.2 Captopril Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Captopril Tablets Distributors
- 9.2.3 Captopril Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst